Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Narcolepsy01:07

Narcolepsy

510
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
510
Amyloid Fibrils03:03

Amyloid Fibrils

11.7K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redefining diagnostic lesional status in temporal lobe epilepsy with artificial intelligence.

Brain : a journal of neurology·2025
Same author

Optimizing Surgical Planning for Epilepsy Patients With Multimodal Neuroimaging and Neurophysiology Integration: A Case Study.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2024
Same author

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.

medRxiv : the preprint server for health sciences·2023
Same author

EEG Abnormalities and Their Radiographic Correlates in a COVID-19 Inpatient Cohort.

Neurology. Clinical practice·2022
Same author

Retrospective comparison of motor and somatosensory MEG mapping-Considerations for better clinical applications.

NeuroImage. Clinical·2022
Same author

Risk of seizure clusters and status epilepticus following rapid and ultra-rapid medication discontinuation during intracranial EEG monitoring.

Epilepsy research·2021
Same journal

Narcolepsy: clinical approach to etiology, diagnosis, and treatment.

Reviews in neurological diseases·2012
Same journal

Orofacial pain following an invasive dental procedure.

Reviews in neurological diseases·2012
Same journal

An update on the diagnosis and management of dementing conditions.

Reviews in neurological diseases·2012
Same journal

The neurology of decreased activity: abulia.

Reviews in neurological diseases·2012
Same journal

Progressive personality and language changes in a 62-year-old woman.

Reviews in neurological diseases·2012
Same journal

A rare cause of headache.

Reviews in neurological diseases·2012
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

1.7K

Lafora disease.

Deepak Madhavan1, Ruben I Kuzniecky

  • 1New York University Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, NY, USA.

Reviews in Neurological Diseases
|October 19, 2006
PubMed
Summary
This summary is machine-generated.

Lafora disease (LD) is a severe, progressive myoclonic epilepsy. This case report details a 20-year-old man with late-onset LD, highlighting diagnostic challenges and the need for further research into treatments.

More Related Videos

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.9K
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases
09:07

Concanavalin A-Based Sedimentation Assay to Measure Substrate Binding of Glucan Phosphatases

Published on: December 23, 2022

1.7K
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.9K
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.4K

Area of Science:

  • Neurology
  • Genetics
  • Epilepsy

Background:

  • Lafora disease (LD) is an autosomal recessive progressive myoclonic epilepsy.
  • Characterized by seizures, neurological deterioration, and often fatal within 10 years of onset.
  • Part of a heterogeneous group of disorders with myoclonic epilepsy and developmental regression.

Purpose of the Study:

  • To report and discuss a unique case of Lafora disease in a 20-year-old male.
  • To highlight clinical elements of LD, including late onset and response to anticonvulsants.
  • To emphasize the need for further research into LD genetics and pathways.

Main Methods:

  • Case report and clinical discussion.
  • Review of patient's medical history and seizure activity.
  • Analysis of neurophysiologic findings relevant to Lafora disease.

Main Results:

  • A 20-year-old male presented with late-onset generalized tonic-clonic seizures starting at age 16.
  • Patient experienced frequent seizures, status epilepticus, and progressive cognitive decline.
  • Clinical presentation and neurophysiologic findings were discussed in context of Lafora disease.

Conclusions:

  • Lafora disease presents unique diagnostic challenges, especially with later onset.
  • Further research is crucial to identify unknown genetic loci and understand the laforin-malin pathway.
  • Current treatment for Lafora disease is palliative, lacking preventative or curative options.